State Board of Administration of Florida Retirement System lowered its stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 0.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 349,461 shares of the medical instruments supplier’s stock after selling 1,272 shares during the period. State Board of Administration of Florida Retirement System owned approximately 0.16% of DENTSPLY SIRONA worth $13,003,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in XRAY. DNB Asset Management AS lifted its stake in DENTSPLY SIRONA by 323.0% in the third quarter. DNB Asset Management AS now owns 110,004 shares of the medical instruments supplier’s stock worth $4,152,000 after acquiring an additional 84,000 shares during the period. Bank of Montreal Can lifted its position in shares of DENTSPLY SIRONA by 65.8% during the third quarter. Bank of Montreal Can now owns 388,396 shares of the medical instruments supplier’s stock valued at $14,658,000 after buying an additional 154,125 shares during the last quarter. First Hawaiian Bank purchased a new stake in shares of DENTSPLY SIRONA during the third quarter valued at about $224,000. Rothschild Investment Corp IL lifted its position in shares of DENTSPLY SIRONA by 239.2% during the third quarter. Rothschild Investment Corp IL now owns 16,415 shares of the medical instruments supplier’s stock valued at $620,000 after buying an additional 11,575 shares during the last quarter. Finally, Seven Eight Capital LP lifted its position in shares of DENTSPLY SIRONA by 5.8% during the third quarter. Seven Eight Capital LP now owns 160,309 shares of the medical instruments supplier’s stock valued at $6,050,000 after buying an additional 8,800 shares during the last quarter. 97.09% of the stock is currently owned by institutional investors and hedge funds.

In related news, insider Markus Boehringer sold 7,373 shares of the stock in a transaction that occurred on Monday, December 3rd. The shares were sold at an average price of $37.86, for a total value of $279,141.78. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.93% of the company’s stock.

Shares of DENTSPLY SIRONA stock traded down $0.05 during midday trading on Monday, hitting $42.57. The company had a trading volume of 12,201 shares, compared to its average volume of 1,586,542. The firm has a market capitalization of $9.48 billion, a P/E ratio of 16.02, a PEG ratio of 2.36 and a beta of 1.06. The company has a quick ratio of 1.14, a current ratio of 1.76 and a debt-to-equity ratio of 0.31. DENTSPLY SIRONA Inc has a 12-month low of $33.93 and a 12-month high of $59.17.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, November 8th. The medical instruments supplier reported $0.38 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.46 by ($0.08). The company had revenue of $928.40 million during the quarter, compared to analysts’ expectations of $951.58 million. DENTSPLY SIRONA had a negative net margin of 41.97% and a positive return on equity of 8.68%. The business’s revenue for the quarter was down 8.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.70 earnings per share. As a group, research analysts anticipate that DENTSPLY SIRONA Inc will post 1.97 earnings per share for the current fiscal year.

Several analysts have commented on the stock. Barclays reissued a “hold” rating and set a $39.00 price target on shares of DENTSPLY SIRONA in a research report on Sunday, January 6th. ValuEngine raised shares of DENTSPLY SIRONA from a “strong sell” rating to a “sell” rating in a research report on Wednesday, October 24th. BidaskClub raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Wednesday, November 21st. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research report on Sunday, January 6th. Finally, Goldman Sachs Group raised shares of DENTSPLY SIRONA from a “sell” rating to a “buy” rating and set a $44.00 price target for the company in a research report on Friday, October 19th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. DENTSPLY SIRONA currently has a consensus rating of “Hold” and a consensus price target of $50.62.

WARNING: “State Board of Administration of Florida Retirement System Sells 1,272 Shares of DENTSPLY SIRONA Inc (XRAY)” was first reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at https://theolympiareport.com/2019/02/11/state-board-of-administration-of-florida-retirement-system-sells-1272-shares-of-dentsply-sirona-inc-xray.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Recommended Story: Marijuana Stocks Investing Considerations

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.